Targeting tissue-resident memory CD8+ T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis.
Li L, Tang W, Zhang Y, Jia M, Wang L, Li Q, Han Q, Peng X, Xie Y, Wu J, Wang Z, Zhen J, Wang X, Liu M, Sun Y, Zhang C, Yi F.
Li L, et al. Among authors: han q.
Mol Ther. 2022 Aug 3;30(8):2746-2759. doi: 10.1016/j.ymthe.2022.04.024. Epub 2022 May 5.
Mol Ther. 2022.
PMID: 35514086
Free PMC article.